{"AdditionalFields":[{"Key":"AACROrganSiteAll","Value":""},{"Key":"AACRTrackAll","Value":"Clinical Trials"},{"Key":"CEHoursPP8","Value":"1.5"},{"Key":"LivecastUrl","Value":""},{"Key":"RelatedArticlesProgPlan","Value":""},{"Key":"SessionCategoryBasic","Value":""},{"Key":"SessionName","Value":"Methods Workshop"},{"Key":"VideoType","Value":""},{"Key":"WebcastIPSessionLink","Value":""},{"Key":"Presentation Count","Value":"6"}],"BoothSponsorshipIdForCalendar":null,"BoothSponsorshipIdForDetail":null,"BoothSponsorshipIdForResult":null,"CSlideId":null,"Color":"","ContentCaptureVendorSpecification":null,"Created":null,"Date":"2024-04-06","Description":"In this session, we will cover: Trials that test multi-drug combinations; Trials with dual endpoints (toxicity and efficacy); Novel statistical methodology to handle patient heterogeneity; the TARGET-CRM Bayesian adaptive design for dose-finding whereby patients with the targeted mutation are permitted to enroll even when a dose-level cohort is full; the Sub-TITE-CRM design using DLT-free time as the primary endpoint, and which borrows\/clusters information across patient strata; Standard operating procedures for real-time data and communication in adaptive trials; and, the DEDUCE (DEsign & conDUCt of dose Escalation trials) app to compare operating characteristics across designs.  The session will also cover phase 2 randomized trials, and single arm phase 3 which resemble phase 2 designs.  In a series of case studies, we will tell the story of the evolution of novel phase 2 trial designs in pediatric oncology and rare tumors, including the use of historical control data.","Duration":90,"EmbargoSessionContentRule":null,"EmbargoSessionContentUntil":null,"End":"4\/6\/2024 9:30:00 AM","EndTime":"09:30","HidePresentationRating":"False","HidePresentations":"False","Id":"498","Key":"d5fb19c9-288c-4118-bb9e-daf06c011612","LastUpdated":"2024-03-07 22:18","LimitCMEToRegistrationCodes":null,"LimitMediaToRegistrationCodes":null,"Location":"Room 29 - Upper Level - Convention Center","MediaSource":"None","MediaSourceDetails":null,"MediaSourceDuration":null,"MediaSourceDurationHMS":null,"Notes":null,"Number":"MW04","OnDemand":"False","OwnerKey":null,"PlayerUrl":null,"PlayerUrlReason":null,"PrimaryCategory":"","PrimaryCategory_keys":"","PrimaryMediaItemId":null,"PrimaryMediaItemKey":null,"RuleStatus":"Incomplete","SearchResultBody":"MW04. Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 1 - Design and Implementation of Novel Phase 1 and 2 Clinical Trials ","SearchResultCalendarDisplayBlock":null,"SearchResultFooter":"Room 29 - Upper Level - Convention Center","SearchResultHeader":"Apr  6 2024  8:00AM","SecondaryCategory":"","SecondaryCategory_keys":"","ShowChatLink":null,"Start":"4\/6\/2024 8:00:00 AM","StartTime":"08:00","Status":"Active","StreamingConfiguration":null,"StreamingKey":null,"ThumbnailUrl":null,"Title":"Biostatistics in Clinical Trials Workshop: Out of the Rut and Beyond the Traditional, Part 1 - Design and Implementation of Novel Phase 1 and 2 Clinical Trials ","Type":null,"TypeKey":null}